Science Explorer Interactive view Map
World rank, all time
#35,843
of 42,892
Rank in China
#3,244
of 3,536
Research works
131
▼ 12% vs 2013–17
Citations
2.2k
16.5 per fractional work
Top-10% rate
27.9%
record average 16.5%
Open access
51%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.05× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 5.34× its world share, 1 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.12× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.44× its world share, 0 worksChemistryComputer Science: 0.25× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMathematics: 3.97× its world share, 1 worksMathematicsDentistry: 0.86× its world share, 0 worksDentistryHealth Professions: 3.15× its world share, 2 worksHealth ProfessionsMedicine: 2.93× its world share, 15 worksMedicineVeterinary: 2.00× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Decision Sciences: 1.39× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.62× its world share, 1 worksEconomics, Econometr…Psychology: 0.44× its world share, 0 worksPsychologySocial Sciences: 0.11× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 5.3×. Every wedge is a field page.

Which keywords describe research at Pfizer (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Epidemiology, Chemotherapy, Prognostic Factors, Immunotherapy, Biomarkers, Targeted Therapy and Electronic Health Records.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 13 words, with their numbers
  1. Epidemiology3▲ 2.9×27 topics
  2. Clinical Trials3▲ 16×9 topics
  3. Chemotherapy2▲ 9.7×12 topics
  4. Immunotherapy2▲ 7.7×8 topics
  5. Prognostic Factors2▲ 13×5 topics
  6. Biomarkers1▲ 7.2×4 topics
  7. Cancer1▲ 3.5×11 topics
  8. Electronic Health Records1▲ 51×2 topics
  9. Targeted Therapy1▲ 21×4 topics
  10. Clinical Practice Guidelines1▲ 7.3×5 topics
  11. Quality of Life1▲ 3.0×6 topics
  12. Genomic Profiling1▲ 38×2 topics
  13. Rituximab1▲ 26×3 topics

Which research topics does Pfizer (China) publish most on?

By volume in 2022–2025: Electronic Health Records Systems, Health Systems, Economic Evaluations, Quality of Life, Advanced Causal Inference Techniques and Lung Cancer Treatments and Mutations.

  1. 1 Electronic Health Records Systems Health Information Management 1 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  3. 3 Advanced Causal Inference Techniques Statistics and Probability 1 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
  6. 6 PARP inhibition in cancer therapy Oncology 0 works
  7. 7 Lung Cancer Research Studies Oncology 0 works
  8. 8 Pneumonia and Respiratory Infections Epidemiology 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.7%not open49.3%

World: 28% of research is openly available.

with international co-authors61.1%domestic only38.9%

World: 19% is written across borders.

How has Pfizer (China)'s research output changed?

Output in 2018–2022 was 12% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.